Rowachol--a possible treatment for cholesterol gallstones.
- 1 April 1979
- Vol. 20 (4), 312-317
- https://doi.org/10.1136/gut.20.4.312
Abstract
It has been claimed that Rowachol, a proprietary choleretic, is occasionally successful in the treatment of gallstones. In gallstone patients we have examined its effect on the lipid composition of (1) samples of fasting gall bladder bile obtained at the time of cholecystectomy, and (2) T-tube bile on the tenth post-operative day. In a dose of two capsules, three times a day for only 48 hours, Rowachol significantly lowered the cholesterol solubility of both gall bladder (P less than 0.001) and T-tube bile (P less than 0.05). Rowachol in a dose of one capsule three times a day for 48 hours did not alter bile composition, while four capsules four times a day for a similar period caused a significant (P less than 0.05) deterioration in biliary lipid composition. The possible mechanisms of action of Rowachol and their therapeutic implications are discussed.This publication has 29 references indexed in Scilit:
- Effect of ioglycamide (Biligram) on bile flow and biliary lipid secretion in man.Gut, 1978
- The Influence of β-sitosterol on Biliary Cholesterol Saturation and Bile Acid Kinetics in ManScandinavian Journal of Gastroenterology, 1978
- URSODEOXYCHOLIC ACID TREATMENT OF GALLSTONESThe Lancet, 1977
- Effect of d-Limonene and related compounds on bile flow and biliary lipid composition in rats and dogsLife Sciences, 1976
- The use ofd-limonene preparation as a dissolving agent of gallstonesDigestive Diseases and Sciences, 1976
- $beta;-SITOSTEROL AND CHENODEOXYCHOLIC ACID IN THE TREATMENT OF CHOLESTEROL GALLSTONESThe Lancet, 1975
- GALLSTONE DISSOLUTION IN MAN USING CHENODEOXYCHOLIC ACIDThe Lancet, 1972
- The solubility of cholesterol in aqueous solutions of bile salts and lecithinZeitschrift Fur Ernahrungswissenschaft, 1971
- The physicochemical basis of cholesterol gallstone formation in manJCI Insight, 1968
- Enzymic Analysis of Steroid HormonesPublished by Wiley ,1960